RPLP1 and cholangiocarcinoma: In all three CCA subtypes, TE effectively inhibited tumour growth, although its impact was somewhat reduced in SNU‐1196 pCCA xenografts compared to CC‐LP‐1 iCCA or TFK‐1 dCCA xenografts.